Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Feb 20 EFFECT Notice of effectiveness
- 13 Feb 20 424B3 Prospectus supplement
- 6 Feb 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Jan 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Dec 19 S-4/A Registration of securities issued in business combination transactions (amended)
- 25 Oct 19 S-4 Registration of securities issued in business combination transactions
VTRS similar filings
Filing view
External links
Exhibit 15.1
December 13, 2019
Pfizer Inc.
New York, New York
Re: Registration Statement on Form S-4 of Upjohn (a business unit of Pfizer Inc.)
With respect to the subject registration statement, we acknowledge our awareness of the use therein of our report dated December 13, 2019 related to our review of interim financial information.
Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.
/s/ KPMG LLP
New York, New York